Published

Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Unknown
Date: 2026-01-15
Source: Europe PMC
DOI: 10.1007/s40263-025-01256-7
PubMed: 41546846

Authors

Rached G Campana A Fiani D Nguyen C Van den Eynde V Gillman PK Barnett BS.

Watch author

Derived topics and classifications

psilocybin Depression Addiction Pharmacology Receptor Pharmacology Review Article Safety Toxicity Drug Interactions Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counselingTherapeutic Advances in Drug Safety · 2026-02-28 Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.Expert Opinion on Drug Safety · 2022-04-26 Opinion Mining of Erowid’s Experience Reports on LSD and Psilocybin-Containing MushroomsDrug Safety · 2025-03-03